Pharmaceutical and Biotech Patent Forum Live Chat Software
World Congress
  

Pharmaceutical and Biotech Patent Forum

Pharmaceutical and Biotech Patent Forum

Connect with in-house counsel to delve into the nuances of patent law for the life sciences at all stages of innovation. Over the course of two days:

  • Hear updates on the latest developments in patent law and enforcement in the U.S. and abroad
  • Design a strong patent strategy to foster innovation and protect new therapies
  • Discuss implications of Brexit on patent enforcement in the UK and Europe
  • Identify the impact of IP on drug pricing and market access
  • Navigate the uncertainty left by Sequenom and Mayo
  • Articulate how interference takes shape by a look into CRISPR
  • Determine appropriate responses to IPR activity in light of Cuozzo
  • Explore the implications of Life Tech v. Promega
  • Consider what’s in store for life sciences under the next Administration

Call for Papers: Submit an Abstract for Presentations

The Pharmaceutical and Biotech Patent Forum is now accepting abstract submissions for 2016!
The deadline is August 31, 2016 Click here for details.

Register Now!
Download Brochure
Follow Us on LinkedIn
Partners
About World Congress

World Congress offers unique conferences and events in health care and pharmaceutical that are unmatched by any other organizer. Through our educationally focused events, we convene CEOs and senior-level executives from all segments of the health care and life sciences industries to exchange ideas, discuss market trends, and explore solutions to the most pressing challenges facing a variety of roles within these organizations.

World Congress © 2016 | All Rights Reserved
500 West Cummings Park, Suite 5400500 West Cummings Park, Suite 5400
             Woburn, MA 01801
500 West Cummings Park, Suite 5400800-767-9499
500 West Cummings Park, Suite 5400[email protected]
500 West Cummings Park, Suite 5400Sitemap
Receive Email Updates

Be the first to learn about our upcoming events, promotions and news.



Connect with Us